The ‘Double’ Call in Human Genome (HGSI)
Human Genome Sciences Inc. (NASDAQ: HGSI) is not getting much of a boost despite being called as stock which could manage to double in price over the next 18 months ...Read Full Story »
Posts related to ‘HGSI double report’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9983)
- Accounting (513)
- Active Trader (4416)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5086)
- Autos (1477)
- Banking & Finance (3796)
- Bankruptcy (283)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1362)
- Consumer Product (796)
- Corporate Governance (1997)
- Dividends & Buybacks (931)
- Earnings (4159)
- Economy (3711)
- Editor's Picks (516)
- ETFs & Mutual Funds (825)
- General (3838)
- Healthcare (1435)
- Housing (1043)
- Industrials (632)
- Infrastructure (605)
- International Markets (4181)
- Internet (2200)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (657)
- Media (4210)
- Mergers & Acquisitions (2229)
- Oil & Gas (2579)
- Personal Finance (309)
- Politics (826)
- Polls (34)
- Regulation (1166)
- Retail (2592)
- Rumors (1093)
- Services (301)
- Special Report (378)
- Technology (3829)
- Telecom & Wireless (1694)
- Transportation (581)
- Value Investing (767)
